Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil “Drug Facts” Booklet Pouch Labeling Proposed For Two-Count Sizes

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare is requesting a six-month deferral from the OTC labeling final rule requirements to implement "booklet pouch" labeling for two-count sizes of five products
Advertisement

Related Content

Novex Pharma labeling deferrals
Novex Pharma labeling deferrals
Novex Pharma labeling deferrals
McNeil labeling deferrals
McNeil labeling deferrals
FDA "Drug Facts" Templates Supersede Reference Listed Drug Labeling - FDA
Labeling exemptions
OTC Labeling Exemption, Deferral Timelines Depend On Complexity - FDA
Pepcid AC Gelcaps Sample Pouch Deferral Granted Without "Drug Facts" Title
Pepcid AC Gelcaps Sample Pouch Deferral Granted Without "Drug Facts" Title

Topics

Advertisement
UsernamePublicRestriction

Register

PS093368

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel